Your browser doesn't support javascript.
loading
PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
Sanchez-Mut, Jose V; Heyn, Holger; Silva, Bianca A; Dixsaut, Lucie; Garcia-Esparcia, Paula; Vidal, Enrique; Sayols, Sergi; Glauser, Liliane; Monteagudo-Sánchez, Ana; Perez-Tur, Jordi; Ferrer, Isidre; Monk, David; Schneider, Bernard; Esteller, Manel; Gräff, Johannes.
Afiliação
  • Sanchez-Mut JV; Laboratory of Neuroepigenetics, Brain Mind Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Heyn H; Centro Nacional de Análisis Genómico (CNAG), Center for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Silva BA; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Dixsaut L; Laboratory of Neuroepigenetics, Brain Mind Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Garcia-Esparcia P; Laboratory of Neuroepigenetics, Brain Mind Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Vidal E; Department of Pathology and Experimental Therapeutics, University of Barcelona, Institut d'Investigació Biomedica de Bellvitge (IDIBELL), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
  • Sayols S; Center for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain.
  • Glauser L; Bioinformatics Core Facility, Institute of Molecular Biology, Mainz, Germany.
  • Monteagudo-Sánchez A; Laboratory of Neuroepigenetics, Brain Mind Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Perez-Tur J; Genomic Imprinting and Cancer Group, Cancer Epigenetics and Biology Program, Institut d'Investigació Biomedica de Bellvitge, Barcelona, Spain.
  • Ferrer I; Institut de Biomedicina de València-CSIC, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Investigación Sanitaria 'La Fe', València, Spain.
  • Monk D; Department of Pathology and Experimental Therapeutics, University of Barcelona, Institut d'Investigació Biomedica de Bellvitge (IDIBELL), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
  • Schneider B; Genomic Imprinting and Cancer Group, Cancer Epigenetics and Biology Program, Institut d'Investigació Biomedica de Bellvitge, Barcelona, Spain.
  • Esteller M; Neurodegenerative Studies Laboratory, Brain Mind Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Gräff J; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program, Institut d'Investigació Biomedica de Bellvitge, Barcelona, Spain.
Nat Med ; 24(5): 598-603, 2018 05.
Article em En | MEDLINE | ID: mdl-29736028
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Locos de Características Quantitativas / Doença de Alzheimer / Amidoidrolases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Locos de Características Quantitativas / Doença de Alzheimer / Amidoidrolases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça